AstraZeneca in billion-dollar deal in AI
AstraZeneca has signed a strategic research collaboration with Chinese pharmaceutical company CSPC Pharmaceuticals Group Limited, based in Shijiazhuang. The collaboration focuses...
Kancera rises on positive results from the KANDOVA study
Kancera has published positive overall results from the KANDOVA study...
New success strengthens Alzinova's licensing opportunities for ALZ-101
Alzinova has presented new data that strengthens the...
BioStock Global Forum 2025 – watch the videos
The largest funders and investors in Scandinavian life science
Scandinavian life science shines brightly on the global...
RFK Jr. appoints new members to vaccine committee
On Tuesday, US Secretary of Health and Human Services Robert F. Kennedy dismissed...
BioInvent focuses on first-line treatment
BioInvent's Phase I dose escalation study of BI-1206, in combination with...
Deep Apple and Novo Nordisk in collaboration on oral drugs
Deep Apple Therapeutics has entered into a research and...
Nvidia and Novo Nordisk collaborate in drug discovery
Nvidia has entered into a collaboration with Novo Nordisk...
Demant acquires KIND for DKK 5,2 billion
The Danish medical technology group Demant has signed an agreement to...
HIV research takes a step forward with mRNA breakthrough
Australian researchers have made significant progress in...
Curasight CEO: “We will deliver important milestones in the next 12 months”
Curasight works with the goal of transforming cancer care through...
RFK Jr. dismisses entire CDC vaccine committee
Robert F. Kennedy Jr., newly appointed Secretary of Health and Human Services in the United States,...
Promising preclinical data for Aqilion's TAK1 program
Last summer, Merck and Aqilion concluded a licensing and...
SynAct Pharma updates development strategy and extends financial sustainability to the end of 2026
On June 4th, SynAct Pharma held a capital markets day...
Biotech funding plummets in the wake of Trump's policies
During the month of May, biotechnology sector funding fell by 57...
Qlife and Hipro want to unite in new diagnostics empire
Qlife Holding has signed a non-binding letter of intent with...
Camurus signs billion-dollar deal with Eli Lilly
The licensing agreement is worth up to $870 million...
Saniona's CFO on the strategy to reach clinical milestones
According to Saniona's Q1 report, the company's current financing will...
Aqilion: "It has been a really busy year"
Summer is upon us and it's time to...
700 million euros allocated to Nordic life science
The Nordic investment company Impilo has closed its Fund...
EU imposes restrictions on Chinese medical technology
European Union member states support a new...
Senzime raises 110 million in private placement
The issue is being carried out without a discount and enables continued commercial...
Regeneron strengthens obesity portfolio
Regeneron Pharmaceuticals has entered into a licensing agreement with Chinese Hansoh...
Xintela's CEO comments on the latest progress
2025 has been full of activities so far for...
Notes
Alligator Bioscience receives FDA approval for phase III mitazalimab dose
Lena Åredal appointed new CEO of SyntheticMR
BioArctic advances phase IIa study with exidavnemab
Novo Nordisk advances amycretin to Phase III
BioNTech acquires CureVac for $1,25 billion
NEWSLETTER
Premium
Cinclus Pharma signs billion-dollar deal with Zentiva
Drug tariffs could increase costs by $51 billion
AstraZeneca in new AI investment
Extensive study points to cannabis' potential in cancer
Eli Lilly's oral weight loss drug impresses in Phase III
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Upcoming events
Investing in Life Science
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...